Type I interferon is selectively required by dendritic cells for immune rejection of tumors

Cancer immunoediting is the process whereby the immune system suppresses neoplastic growth and shapes tumor immunogenicity. We previously reported that type I interferon (IFN-α/β) plays a central role in this process and that hematopoietic cells represent critical targets of type I IFN’s actions. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamond, Mark S., Kinder, Michelle, Matsushita, Hirokazu, Mashayekhi, Mona, Dunn, Gavin P., Archambault, Jessica M., Lee, Hsiaoju, Arthur, Cora D., White, J. Michael, Kalinke, Ulrich, Murphy, Kenneth M., Schreiber, Robert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182061/
https://www.ncbi.nlm.nih.gov/pubmed/21930769
http://dx.doi.org/10.1084/jem.20101158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182061/
https://www.ncbi.nlm.nih.gov/pubmed/21930769
http://dx.doi.org/10.1084/jem.20101158

Ejemplares similares